Thus, the findings imply that the ApoE4-mediated increased risk of developing depression could be partially attributed to the upregulation of 5-HT2A and downregulation of BDNF signaling in ApoE4 carriers compared with carriers of the other two isoforms. Here, HTR2A is linked to depressive symptom measurement.